Literature DB >> 18585959

Local immunological factors associated with recurrence of mucosal leishmaniasis.

Felipe Francisco Tuon1, Adriano Gomes-Silva, Alda Maria Da-Cruz, Maria Irma Seixas Duarte, Vicente Amato Neto, Valdir Sabbaga Amato.   

Abstract

Recurrence of mucosal leishmaniasis (ML) is frequent, but the causative mechanisms are unknown. Our aim was to compare cellular and cytokine patterns of lesions from ML that evolved to recurrence or cure in order to determine the risk factor associated with recurrence. Lesions were evaluated by immunohistochemistry before and after therapy, and patients were followed-up for five years. Higher levels of CD4(+) T and IFN-gamma-producing cells were detected in active lesions and decreased after therapy. Macrophages and IL-10 were markedly increased in cured patients. Conversely, CD8(+) T and NK cells were higher in relapsed than in cured cases. Notably, a decrease in these cells in addition to decreased IL-10 and IFN-gamma was also observed after therapy. These data suggest that exacerbated CD8(+) activity, in addition to a poor regulatory response, could underlie an unfavorable fate with regard to ML. These markers may be useful for predicting the prognosis of ML in lesion studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18585959     DOI: 10.1016/j.clim.2008.05.007

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  23 in total

Review 1.  Systematic review of biomarkers to monitor therapeutic response in leishmaniasis.

Authors:  Anke E Kip; Manica Balasegaram; Jos H Beijnen; Jan H M Schellens; Peter J de Vries; Thomas P C Dorlo
Journal:  Antimicrob Agents Chemother       Date:  2014-11-03       Impact factor: 5.191

2.  Regulatory T-Cell Dynamics in Cutaneous and Mucocutaneous Leishmaniasis due to Leishmania braziliensis.

Authors:  Nicolas Barros; Nestor Vasquez; Fernando Woll; Cesar Sanchez; Braulio Valencia; Alejandro Llanos-Cuentas; A Clinton White; Martin Montes
Journal:  Am J Trop Med Hyg       Date:  2018-02-01       Impact factor: 2.345

3.  Quantitative Kinetoplast DNA Assessment During Treatment of Mucosal Leishmaniasis as a Potential Biomarker of Outcome: A Pilot Study.

Authors:  Marlene Jara; Braulio Mark Valencia; Vanessa Adaui; Milena Alba; Rachel Lau; Jorge Arevalo; Alejandro Llanos-Cuentas; Andrea K Boggild
Journal:  Am J Trop Med Hyg       Date:  2015-10-19       Impact factor: 2.345

4.  The skin homing receptor cutaneous leucocyte-associated antigen (CLA) is up-regulated by Leishmania antigens in T lymphocytes during active cutaneous leishmaniasis.

Authors:  C de O Mendes-Aguiar; A Gomes-Silva; E Nunes; R Pereira-Carvalho; R S Nogueira; M de P Oliveira-Neto; A L Bertho; A M Da-Cruz
Journal:  Clin Exp Immunol       Date:  2009-09       Impact factor: 4.330

5.  Association of the Endobiont Double-Stranded RNA Virus LRV1 With Treatment Failure for Human Leishmaniasis Caused by Leishmania braziliensis in Peru and Bolivia.

Authors:  Vanessa Adaui; Lon-Fye Lye; Natalia S Akopyants; Mirko Zimic; Alejandro Llanos-Cuentas; Lineth Garcia; Ilse Maes; Simonne De Doncker; Deborah E Dobson; Jorge Arevalo; Jean-Claude Dujardin; Stephen M Beverley
Journal:  J Infect Dis       Date:  2015-06-29       Impact factor: 5.226

6.  Secondary Prophylaxis with Liposomal Amphotericin B in a Patient with Mucosal Leishmaniasis Undergoing Immunobiological Therapy for Active Ankylosing Spondylitis.

Authors:  Antonio Carlos Nicodemo; Heitor Franco de Andrade; Pablo Muñoz Torres; Valdir Sabbaga Amato
Journal:  Am J Trop Med Hyg       Date:  2019-08       Impact factor: 2.345

7.  Immunological perspectives of leishmaniasis.

Authors:  Susanne Nylén; Shalini Gautam
Journal:  J Glob Infect Dis       Date:  2010-05

8.  Interleukin 17 production among patients with American cutaneous leishmaniasis.

Authors:  Olívia Bacellar; Daniela Faria; Márcia Nascimento; Thiago M Cardoso; Kenneth J Gollob; Walderez O Dutra; Phillip Scott; Edgar M Carvalho
Journal:  J Infect Dis       Date:  2009-07-01       Impact factor: 5.226

9.  Reactivation of mucosal and cutaneous leishmaniasis in a renal transplanted patient.

Authors:  Felipe F Tuon; Giovana Marina Bombonatto; Eveline Roesler Battaglin; Marcus Henrique Sakumoto; Valdir Sabbaga Amato; Raphael Abegão de Camargo; Antônio Carlos Nicodemo
Journal:  Am J Trop Med Hyg       Date:  2014-04-14       Impact factor: 2.345

10.  Immunobiology of visceral leishmaniasis.

Authors:  Rajiv Kumar; Susanne Nylén
Journal:  Front Immunol       Date:  2012-08-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.